158 related articles for article (PubMed ID: 2265765)
1. Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.
Larsen M; Hommel E; Parving HH; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):505-9. PubMed ID: 2265765
[TBL] [Abstract][Full Text] [Related]
2. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
Parving HH; Larsen M; Hommel E; Lund-Andersen H
Diabetologia; 1989 Jul; 32(7):440-4. PubMed ID: 2680698
[TBL] [Abstract][Full Text] [Related]
3. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
4. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.
Parving HH
Diabetes Care; 1991 Mar; 14(3):260-9. PubMed ID: 2044441
[TBL] [Abstract][Full Text] [Related]
5. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
Parving HH; Hommel E; Jensen BR; Hansen HP
Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
[TBL] [Abstract][Full Text] [Related]
6. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
Parving HH; Hommel E; Damkjaer Nielsen M; Giese J
BMJ; 1989 Aug; 299(6698):533-6. PubMed ID: 2507061
[TBL] [Abstract][Full Text] [Related]
7. Blood-retina barrier permeability in diabetes during acute ACE-inhibition.
Engler CB; Parving HH; Mathiesen ER; Larsen M; Lund-Andersen H
Acta Ophthalmol (Copenh); 1991 Oct; 69(5):581-5. PubMed ID: 1776410
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
Mathiesen ER; Hommel E; Giese J; Parving HH
BMJ; 1991 Jul; 303(6794):81-7. PubMed ID: 1860008
[TBL] [Abstract][Full Text] [Related]
9. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
10. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
11. A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study Group.
Bain R; Rohde R; Hunsicker LG; McGill J; Kobrin S; Lewis EJ
J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S97-103. PubMed ID: 1457767
[TBL] [Abstract][Full Text] [Related]
12. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
Engler CB; Sander B; Larsen M; Koefoed P; Parving HH; Lund-Andersen H
Acta Ophthalmol (Copenh); 1994 Dec; 72(6):663-7. PubMed ID: 7747571
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects: a two-year trial.
Chase HP; Garg SK; Harris S; Hoops S; Jackson WE; Holmes DL
Ann Ophthalmol; 1993 Aug; 25(8):284-9. PubMed ID: 8239321
[TBL] [Abstract][Full Text] [Related]
14. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
Ratzmann KP; Raskovic M; Schimke E
Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
[TBL] [Abstract][Full Text] [Related]
15. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
Insua A; Ribstein J; Mimran A
Postgrad Med J; 1988; 64 Suppl 3():59-62; discussion 90-2. PubMed ID: 3074298
[TBL] [Abstract][Full Text] [Related]
16. Effects of captopril on diabetic nephropathy in hypertensive women.
Gonzalez-Sicilia de Llamas L; Garcia Alberola A; Lafuente Lopez-Herrera M; Fuente Jimenez T; Fernandez Pardo J; Hernandez Cascales J
Eur J Clin Pharmacol; 1991; 41(5):405-9. PubMed ID: 1761066
[TBL] [Abstract][Full Text] [Related]
17. Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
Romanelli G; Giustina A; Bossoni S; Caldonazzo A; Cimino A; Cravarezza P; Giustina G
Diabetes; 1990 Nov; 39(11):1333-8. PubMed ID: 2227107
[TBL] [Abstract][Full Text] [Related]
18. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
[TBL] [Abstract][Full Text] [Related]
19. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
Mimran A; Insua A; Ribstein J; Bringer J; Monnier L
Diabetes Care; 1988; 11(10):850-3. PubMed ID: 3073076
[TBL] [Abstract][Full Text] [Related]
20. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome.
Hod M; van Dijk DJ; Karp M; Weintraub N; Rabinerson D; Bar J; Peled Y; Erman A; Boner G; Ovadia J
Nephrol Dial Transplant; 1995 Dec; 10(12):2328-33. PubMed ID: 8808235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
